US Biosimilars Market - US biotech market,US Aerospace Market

News and headlines about US Biosimilars Market all over the world. Collection of breaking news from United States, Europe, Asia and other country to show news about US Biosimilars Market,US biotech market.

• Biosimilars Expected to Take Toll on Amgen

  By Krishna Sharma on April 10, 2012 - Biosimilar competition to multiple drugs is expected to reduce Amgens sales by nearly US$ 9 Billion during 2013-2020 ... [+]

  Read more
  Biogenrics market       Biosimilar industy       Biosimilar market       Us bisimilar market

• Patent Expiration of Blockbuster Biologics Leading Splendid Growth of Global Biosimilars

  By Shushmul Maheshwari on March 16, 2012 - Globally, biosimilars are anticipated to witness US$ 2.5 Billion growth by 2015-end, growing at a double-digit rate, says RNCOS. ... [+]

  Read more
  Global biologics market       Global Biosimilars Market       Global HGH Biosimilars Market

• Aarkstore-Biosimilars Update-Market Resarch Report

  By harsha on March 19, 2012 - From Canada and the US to Japan, the EU and Australia, regulators around the world are establishing guidelines that will pave the way for competition between biosimilars... [+]

  and costly biologics. Read more
  Aarkstore Enterprise       Biosimilars       immunogenicity       update

Latest news headlines about US Biosimilars Market of US. Browse the following news to get noticed with trends, events and spotlight about US Biosimilars Market,US biotech market.

• Aarkstore.com The World Market for Biosimilars and the Potential for US Follow on Biologics

  By dipti gaikar on April 11, 2012 - Aarkstore.com announce a new report "The World Market for Biosimilars and the Potential for US Follow on Biologics" through its vast collection of market... [+]

  research report. Read more
  

• Amgen to be the Worst Hit from US Biosimilar Erosion During 2011 – 2020

  By Krishna Sharma on October 10, 2011 - A new report from IMARC Group expects Amgen to lose brand sales worth US$ 8.4 Billion during 2010 and 2020 mainly as a result of biosimilar erosion. ... [+]

  Read more
  amgen       Biosimilar market       Biosimilars       enbrel       Epoetin Alpha       Epogen       Ethanercept       US Biosimilars Market

• The Market for Biosimilars Will be a Marathon and Not a Sprint

  By Krishna Sharma on July 26, 2011 - A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market , however, is expected to be a marathon... [+]

  and not a sprint. Read more
  biopharmaceutical       Biosimilars       Epoetin Alfa       growth hormones       Omnitrope       small molecule generics       somatropin       US Biosimilar Market

Latest news headlines about US Biosimilars Market of UK. Browse the following news to get noticed with trends, events and spotlight about US Biosimilars Market,US biotech market.

• Indian Biosimilars Industry Poised for Immense Growth

  By Shushmul Maheshwari on July 26, 2011 - With more than 130 companies in the biopharmaceutical market, the Indian biosimilars industry is all set for incessant growth in the coming years, says RNCOS. ... [+]

  Read more
  Global Biosimilars Market       Global Erythropoietin Market       US Biosimilars Market

• Biosimilar Insulin Products in the US to Grow at a CAGR of 74 Percent over the Period 2013-2020

  By Krishna Sharma on January 25, 2012 - Lantus is expected to be the most lucrative target for biosimilar manufacturers and account for 71% of the total biosimilar Insulin sales by 2020. ... [+]

  Read more
  biosimilars market       Insulin Market       US Biosimilars Market

• The Penetration of Biosimilars in the US Will Vary Across Different Biological Classes

  By Krishna Sharma on January 12, 2012 - The volume penetration of biosimilars in the US will strongly depend upon the complexity of the molecule, the patient pool that it caters and the extent of savings... [+]

  it brings to payers and providers Read more
  Biosimilar market       Biosimilars indurtry       U.S biosimilar market

Latest news headlines about US Biosimilars Market of Canada. Browse the following news to get noticed with trends, events and spotlight about US Biosimilars Market,US biotech market.

• Biosimilars for Blood Disorder Indications in the US Will Reach More Than US$ 2.4 Billion in 2020

  By Krishna Sharma on November 16, 2011 - Biosimilar versions of Epogen (Epoetin Alfa) may be launched as early as 2013. This launch is expected to be followed by launches of biosimilar versions of Neupogen... [+]

  (Filgrastim) and Neulasta (Pegfilgr Read more
  Global biologics market       Global follow on market       US Biosimilar Market

• IMARC Group Releases the Most Robust Long Range Market Forecast on the US Biosimilar/Follow-on...

  By Krishna Sharma on October 18, 2011 - With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. ... [+]

  Read more
  bio logistis       Biosimilars       Biosimilars indurtry

• The Market for Biopharmaceuticals was Worth USD 101 Billion in 2010

  By Krishna Sharma on August 1, 2011 - A new report from IMARC Group expects the global market for biopharmaceuticals to reach revenues worth US$ 167 Billion by 2015. ... [+]

  Read more
  Biopharmaceuticals Market       Biosimilars       Conditional Reimbursement       Generic Threat       monoclonal antibodies       purified proteins       recombinant proteins

Latest news headlines about US Biosimilars Market of India. Browse the following news to get noticed with trends, events and spotlight about US Biosimilars Market,US biotech market.

• Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs...

  By Rajesh Gunnam on March 17, 2011 - The report provides a comprehensive insight into the biosimilar market. It offers geography-wise as well as category-wise market forecasts for biosimilars and provides... [+]

  the drivers and restraints affec Read more
  Biosimilars       fda       Pharmaceuticals and Healthcar

• Biogenerics 2005: A New Level of Complexity

  By Bharat Book Bureau on April 10, 2007 - Biogenerics 2005: A New Level of Complexity Biogenerics (or biosimilars, or follow-on proteins) could now enter the EU market in a matter of months, and the... [+]

  US by 2009. Read more